tiprankstipranks
Verve Therapeutics (VERV)
NASDAQ:VERV
US Market

Verve Therapeutics (VERV) Income Statement

Compare
577 Followers

Verve Therapeutics Income Statement

Last quarter (Q4 2024), Verve Therapeutics's total revenue was $13.08M, an increase of 154.28% from the same quarter last year. In Q4, Verve Therapeutics's net income was $-50.03M. See Verve Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 32.33M$ 11.76M$ 1.94M$ 0.00$ 0.00
Gross Profit
$ 32.33M$ 6.30M$ -4.77M$ -3.38M$ -1.33M
Operating Expenses
$ 260.99M$ 234.88M$ 167.63M$ 87.07M$ 40.63M
Depreciation and Amortization
$ 0.00$ 5.46M$ 6.71M$ 3.38M$ 1.33M
EBITDA
$ -228.66M$ -217.67M$ -162.88M$ -85.53M$ -39.30M
Operating Income
$ -228.66M$ -223.12M$ -165.69M$ -87.07M$ -40.63M
Other Income/Expenses
$ 30.30M$ 23.33M$ 8.35M$ -33.25M$ -5.08M
Pretax Income
$ -198.36M$ -199.79M$ -157.33M$ -120.31M$ -45.70M
Net Income
$ -198.71M$ -200.07M$ -157.39M$ -118.64M$ -45.54M
Per Share Metrics
Basic EPS
$ -2.36$ -3.12$ -2.91$ -2.45$ -0.94
Diluted EPS
$ -2.35$ -3.12$ -2.91$ -2.45$ -0.94
Weighted Average Shares Outstanding
84.23M 64.18M 54.02M 48.51M 48.22M
Weighted Average Shares Outstanding (Diluted)
84.63M 64.18M 54.02M 48.51M 48.22M
Currency in USD

Verve Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis